Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities

Journal of Hospital Infection

Volumn 63, Issue SUPPL. 1, 2006, Pages 1-44

  Coia, J E ^a   Duckworth, G J ^b   Edwards, D I ^c   Farrington, M ^d   Fry, C ^c   Humphreys, H ^e   Mallaghan, C ^b   Tucker, D R ^f  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c Addenbrooke's Hospital ^*  (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e BEAUMONT HOSPITAL   (Ireland)

^f ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Antibiotic stewardship; Antisepsis; Colonisation; Cross infection; Decontamination; Disease reservoirs; Handwashing; Infection control; Methicillin resistance; Meticillin; Microbial drug resistance; Patient isolation; Population surveillance; Staphylococcus aureus; Vancomycin resistance; Workload

Indexed keywords

BENZALKONIUM CHLORIDE; CEPHALOSPORIN DERIVATIVE; CHLORHEXIDINE; OILATUM; OILATUM PLUS; PARAFFIN; POLYPEPTIDE ANTIBIOTIC AGENT; POVIDONE IODINE; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TRICLOSAN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASEPSIS; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; BACTERIUM COLONY; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLEANING; CLINICAL LABORATORY; CONSULTATION; DISEASE SEVERITY; DISEASE SURVEILLANCE; DRUG FORMULATION; DRUG MISUSE; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NOSE; NURSE; PATIENT CARE; PATIENT SELECTION; PERSONNEL MANAGEMENT; PRACTICE GUIDELINE; PREVALENCE; RISK ASSESSMENT; SCREENING TEST; SKIN; STAPHYLOCOCCUS INFECTION; UNITED KINGDOM; WASTE MANAGEMENT;

EID: 33645921976     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2005.10.014     Document Type: Review

References (196)

1. Report of a Combined Working Party of the Hospital Infection Society and British Society for Antimicrobial Chemotherapy. Guidelines for the control of meticillin-resistant Staphylococcus aureus. J Hosp Infect 7 (1986) 193-201
2. Working Party Report. Guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus. J Hosp Infect 16 (1990) 351-377
3. Duckworth G., Cookson B., Humphreys H., and Heathcock R. Revised methicillin-resistant Staphylococcus aureus infection control guidelines for hospitals. Report of a Working Party of the British Society for Antimicrobial Chemotherapy, the Hospital Infection Society and the Infection Control Nurses Association. J Hosp Infect 39 (1998) 253-290
4. Brown D.F.J., Edwards D.I., Hawkey P.M., et al. Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). J Antimicrob Chemother 56 (2005) 1000-1018
5. Jevons M.P. Celbenin-resistant staphylococci. BMJ 1 (1961) 124-125
6. Barber M. Methicillin-resistant staphylococcus. J Clin Pathol 14 (1961) 385-393
7. Harbarth S., and Pittet D. Methicillin-resistant Staphylococcus aureus. Lancet Infect Dis 5 (2005) 653-663
8. Hiramatsu K. Reduced susceptibility of Staphylococcus aureus to vancomycin - Japan, 1996. MMWR Morb Mortal Wkly Rep 46 (1997) 624-626
9. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin - United States. JAMA 288 (2002) 824-825
10. European Antimicrobial Resistance Surveillance System (EARSS). Annual report EARSS - 2003 (2004), RIVM, Bilthoven, The Netherlands
11. Salgado C.D., Farr B.M., and Calfee D.P. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 36 (2003) 131-139
12. Communicable Disease Surveillance Centre, Public Health Laboratory Service. Antimicrobial resistance in 2000. England and Wales (2002), Public Health Laboratory Service, London
13. Johnson A.P., Pearson A., and Duckworth G. Surveillance and epidemiology of MRSA bacteraemia in the UK. J Antimicrob Chemother 56 (2005) 455-462
14. McDonald P., Mitchell E., Johnson H., et al. Epidemiology of MRSA: the north/south study of MRSA in Ireland 1999. J Hosp Infect 54 (2003) 130-134
15. Tiemersma E.W., Bronzwaer S.L.A.M., Lyytikäinen O., et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 10 (2004) 1627-1634
16. Lacey R.W. Multi-resistant Staphylococcus aureus - a suitable case for inactivity?. J Hosp Infect 9 (1987) 103-105
17. Barrett S.P., Mummery R.V., and Chattopadhyay B. Trying to control MRSA causes more problems than it solves. J Hosp Infect 39 (1998) 85-93
18. Teare E.L., and Barret S.P. Stop the ritual of tracing colonised people. BMJ 314 (1997) 665-666
19. Farrington M., Redpath C., Trundle C., Coomber S., and Brown N.M. Winning the battle but losing the war: methicillin-resistant Staphylococcus aureus (MRSA) infection at a teaching hospital. Q J Med 91 (1998) 539-548
20. Shannon T., Edgar P., Villarreal C., Herndon D.N., Phillips L.G., and Heggers J.P. Much ado about nothing: methicillin-resistant Staphylococcus aureus. J Burn Care Rehabil 18 (1997) 326-331
21. Kotilainen P., Routamaa M., Peltonen R., et al. Elimination of epidemic methicillin-resistant Staphylococcus aureus from a university hospital and district institutions, Finland. Emerg Infect Dis 9 (2003) 169-175
22. Kerttula A.-M., Lyytikäinen O., Salmenlinna S., and Vuopio-Varkila J. Changing epidemiology of methicillin-resistant Staphylococcus aureus in Finland. J Hosp Infect 58 (2004) 109-114
23. Rubinovitch B., and Pittet D. Screening for methicillin-resistant Staphylococcus aureus in the endemic hospital: what have we learned?. J Hosp Infect 47 (2001) 9-18
24. Boyce J.M., Havill N.L., Kohan C., Dumigan D.G., and Ligi C.E. Do infection control measures work for methicillin-resistant Staphylococcus aureus?. Infect Control Hosp Epidemiol 25 (2004) 395-401
25. McBryde E.S., Bradley L.C., Whitby M., and McElwain D.L.S. An investigation of contact transmission of methicillin-resistant Staphylococcus aureus. J Hosp Infect 58 (2004) 104-108
26. Grundmann H., Hori S., Winter B., Tami A., and Austin D.J. Risk factors for the transmission of methicillin-resistant Staphylococcus aureus in an adult intensive care unit: fitting a model to the data. J Infect Dis 185 (2002) 481-488
27. Muto C.A., Jernigan J.A., Ostrowsky B.E., et al. SHEA guidelines for preventing nosocomial transmission of multi-drug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 24 (2003) 362-386
28. Srinivasan A., Dick J.D., and Perl T.M. Vancomycin resistance in staphylococci. Clin Microbiol Rev 15 (2002) 430-438
29. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morb Mortal Wkly Rep 51 (2002) 565-567
30. Anon. Report: Deaths involving MRSA: England and Wales, 1999-2003. Health Stat Q 25 (2005) 60-65
31. Selvey L.A., Whitby M., and Johnson B. Nosocomial methicillin-resistant Staphylococcus aureus bacteremia: is it any worse than nosocomial methicillin-sensitive Staphylococcus aureus bacteremia?. Infect Control Hosp Epidemiol 21 (2000) 645-648
32. Romero-Vivas J., Rubio M., Fernandez C., and Picazo J.J. Mortality associated with nosocomial bacteraemia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 21 (1995) 1417-1423
33. Whitby M., McLaws M.-L., and Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust 175 (2001) 264-267
34. Cosgrove S.E., Sakoulas G., Perencevich E.N., Schwaber M.J., Karchmer A.W., and Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36 (2003) 53-59
35. Rello J., Torres A., Ricart M., et al. Ventilator-associated pneumonia by Staphylococcus aureus: comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 150 (1994) 1545-1549
36. Engeman J.J., Carmeli Y., Cosgrove S.E., et al. Adverse clinical and economic outcomes attributable to methicillin resistance amongst patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 36 (2003) 592-598
37. Stamm A.M., Long M.N., and Belcher B. Higher overall nosocomial infection rate because of increased attack rate of methicillin-resistant Staphylococcus aureus. Am J Infect Control 21 (1993) 70-74
38. Abramson M., and Sexton D.J. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteraemia: at what costs?. Infect Control Hosp Epidemiol 20 (1999) 408-411
39. Kim T., Oh P.I., and Simor A.E. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol 22 (2001) 99-104
40. Vriens M., Blok H., Fluit A., Troelstra A., van der Werken C., and Verhoef J. Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch university medical centre: a 10 year survey. Eur J Clin Microbiol Infect Dis 21 (2002) 782-786
41. Chaix C., Durand-Zaleski I., Alberti C., and Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus. A cost-benefit analysis in an intensive care unit. JAMA 282 (1999) 1745-1751
42. Karchmer T.B., Durbin L.J., Simonton B.M., and Farr B.M. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 51 (2002) 126-132
43. Harbarth S., Martin Y., Rohner P., Henry N., Auckenthaler R., and Pittet D. Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus. J Hosp Infect 46 (2000) 43-49
44. Cooper B.S., Stone S.P., Kibbler C.C., et al. Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ 329 (2004) 1-8
45. Souweine B., Traore O., Aublet-Cuvelier B., et al. Role of infection control measures in limiting morbidity associated with multi-resistant organisms in critically ill patients. J Hosp Infect 45 (2000) 107-116
46. Blumberg L.H., and Klugman K.P. Control of methicillin-resistant Staphylococcus aureus bacteraemia in high-risk areas. Eur J Clin Microbiol Infect Dis 13 (1994) 82-85
47. Stone S., Kibbler C., How A., and Balestrini A. Feedback is necessary in strategies to reduce hospital acquired infection. BMJ 321 (2000) 302
48. Cosseron-Zerbib M., Roque Afonson A.M., Naas T., et al. A control programme for MRSA (methicillin-resistant Staphylococcus aureus) containment in a paediatric intensive care unit: evaluation and impact on infections caused by other micro-organisms. J Hosp Infect 40 (1998) 225-235
49. Valls V., Gómez-Herruz P., González-Palacios R., et al. Long-term efficacy of a program to control methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 13 (1994) 90-95
50. Rumbak M.J., and Cancio M.R. Significant reduction in methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia associated with the institution of a prevention protocol. Crit Care Med 23 (1995) 1200-1203
51. Cepeda J.A., Whitehouse T., Cooper B., et al. Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 365 (2005) 295-304
52. Huskins W.C., and Goldmann D.A. Controlling methicillin-resistant Staphylococcus aureus, aka 'Superbug'. Lancet 365 (2005) 273-275
53. Papia G., Louie M., Tralla A., et al. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective?. Infect Control Hosp Epidemiol 20 (1999) 473-477
54. Kunori T., Cookson B., Roberts J.A., Stone S., and Kibbler C.C. Cost-effectiveness of different MRSA screening methods. J Hosp Infect 51 (2002) 189-200
55. Rampling A., Wiseman S., Davis L., et al. Evidence that hospital hygiene is important in the control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 49 (2001) 109-116
56. Haley R.W., Culver D.H., White J.W., et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 121 (1984) 182
57. Curran E.T., Benneyan J.C., and Hood J. Controlling methicillin-resistant Staphylococcus aureus: a feedback approach using annotated statistical process control charts. Infect Control Hosp Epidemiol 23 (2002) 13-18
58. Coello R., Fernández C., Arroyo P., et al. Success and failure in the control of methicillin-resistant Staphylococcus aureus. In: Coello R., Casewell M.W., et al. (Eds). Methicillin-resistant Staphylococcus aureus (1993), Wells Medical Limited, Royal Tunbridge Wells, Kent 95-98
59. Hartstein A.I., Denny M.A., Morthland V.H., and LeMonte A.M. Control of methicillin-resistant Staphylococcus aureus in a hospital and an intensive care unit. Infect Control Hosp Epidemiol 16 (1995) 405-411
60. Spicer J.W. Three strategies in the control of staphylococci including methicillin-resistant Staphylococcus aureus. J Hosp Infect 5 Suppl. A (1995) 45-49
61. Vandenbroucke-Grauls C.M. Control of methicillin-resistant Staphylococcus aureus in the Netherlands. In: Coello R., and Casewell M.W. (Eds). Methicillin-resistant Staphylococcus aureus (1993), Wells Medical Limited, Royal Tunbridge Wells, Kent 75-78
62. Curran E. MRSA: monitoring quality. Br J Infect Control 2 (2000) 20-23
63. Gaynes R.P. Surveillance of nosocomial infections. In: Bennett J.V., and Brachman P.S. (Eds). Hospital infections (1998), Lippincott-Raven, Boston 65-84
64. Giesecke J. Routine surveillance of infectious diseases. In: Giesecke J. (Ed). Modern infectious disease epidemiology (2002), Arnold, London 148-159
65. Public Health Laboratory Service. The first year of the Department of Health's mandatory MRSA bacteraemia surveillance scheme in acute NHS Trusts in England: April 2001-March 2002. CDR Wkly 12 25 (2002) 1-17. http://www.hpa.org.uk/cdr/PDFfiles/2002/cdr2502.pdf Last accessed 26 January 2006
66. Department of Health Press Release. New MRSA figures published. Available on Department of Health (UK) website at: http://www.dh.gov.uk/PublicationsAndStatistics/PressReleases/PressReleases/Notices/fs/en?CONTENT_ID=4085856&chk=WsJjaB; http://www.dh.gov.uk/assetRoot/04/08/58/94/04085894.pdf2004. Last accessed 26 January 2006.
67. Health Protection Agency Communicable Disease Surveillance Centre for the Department of Health 2005. MRSA surveillance system - results. Available on Department of Health's website at:. http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsStatistics/PublicationsStatisticsArticle/fs/en?CONTENT_ID=4085951&chk=HBt2QD Last accessed 26 January 2006
68. Department of Health. Bloodborne MRSA infection rates to be halved by 2008 (2004), Department of Health, London. Available from: http://www.dh.gov.uk/PublicationsAndStatistics/PressReleases/PressReleasesNotices/fs/en?CONTENT_ID+4093533&chk+MY%BkD/ Last accessed 26 January 2006
69. Enright M.C., Robinson D.A., Randle G., Feil E.J., Grundmann H., and Spratt B.G. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 99 (2002) 7687-7692
70. Thomas J.C., Bridge J., Waterman S., Vogt J., Kilman L., and Hancock G. Transmission and control of methicillin-resistant Staphylococcus aureus in a skilled nursing facility. Infect Control Hosp Epidemiol 10 (1989) 106-110
71. Shimada M., Kamakura T., Itasaka H., Matsumata T., Hashizume M., and Sugimachi K. The significance of methicillin-resistant Staphylococcus aureus infection in general surgery: a multivariate analysis of risk factors and preventive approaches. Surg Today 23 (1993) 880-884
72. Onorato M., Borucki M.J., Baillargeon G., et al. Risk factors for colonization or infection due to methicillin-resistant Staphylococcus aureus in HIV-positive patients: a retrospective case-control study. Infect Control Hosp Epidemiol 20 (1999) 26-30
73. Washio M., Mizoue T., Kajioka T., et al. Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a Japanese geriatric hospital. Public Health 111 (1997) 187-190
74. Safdar N., and Maki D.G. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, Gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 136 (2002) 834-844
75. Dziekan G., Hahn A., Thune K., et al. Methicillin-resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study. J Hosp Infect 46 (2000) 263-270
76. Hori S., Sunley R., Tami A., and Grundmann H. The Nottingham Staphylococcus aureus population study: prevalence of MRSA among the elderly in a university hospital. J Hosp Infect 50 (2002) 25-29
77. Crowcroft N.S., Ronveaux O., Monnet D.L., and Mertens R. Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals. Infect Control Hosp Epidemiol 20 (1999) 31-36
78. Campillo B., Dupeyron C., and Richardet J.P. Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis. Epidemiol Infect 127 (2001) 443-450
79. Frank M.O., Batteiger B.E., Sorensen S.J., et al. Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program. Clin Perform Qual Health Care 5 (1997) 180-188
80. Fukatsu K., Saito H., Matsuda T., Ikeda S., Furukawa S., and Muto T. Influences of type and duration of antimicrobial prophylaxis on an outbreak of methicillin-resistant Staphylococcus aureus and on the incidence of wound infection. Arch Surg 132 (1997) 1320-1325
81. Stelfox H.T., Bates D.W., and Redelmeier D.A. Safety of patients isolated for infection control. JAMA 290 (2003) 1899-1905
82. Paterson D.L. Reduced susceptibility of Staphylococcus aureus to vancomycin - a review of current knowledge. Commun Dis Intell 23 (1999) 69-73
83. Fridkin S.K., Lawton R., Edwards J.R., Tenover F.C., McGowan Jr. J.E., and Gaynes R.P. Monitoring antimicrobial use and resistance: comparison with a national benchmark on reducing vancomycin use and vancomycin-resistant enterococci. Emerg Infect Dis 8 (2002) 702-707
84. Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep 44 (1995) 1-33
85. Sanford M.D., Widmer A.F., Bale M.J., Jones R.N., and Wenzel R.P. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 19 (1994) 1123-1128
86. New Zealand Ministry of Health. Guidelines for the control of methicillin-resistant Staphylococcus aureus in New Zealand (2002), New Zealand Ministry of Health, Wellington. http://www.moh.govt.nz/cd/mrsa Accessed 9 January 2005
87. Farr B.M., and Jarvis W.R. Would active surveillance cultures help control healthcare-related methicillin-resistant Staphylococcus aureus infection?. Infect Control Hosp Epidemiol 23 (2002) 65-68
88. Jernigan J.A., Titus M.G., Groschel D.R.M., Getchell-White S.L., and Farr B.M. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 142 (1996) 496-504
89. Salmenlinna S., Lyytikainen O., Kotilainen P., Scotford R., Siren E., and Vuopio-Varkila J. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Finland. Eur J Clin Microbiol Infect Dis 19 (2000) 101-107
90. Thompson R.L., Cabezudo I., and Wenzel R.P. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 97 (1982) 309-317
91. Haley R.W., Cushion N.B., Tenover F.C., et al. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis 171 (1995) 614-624
92. Jernigan J.A., Clemence M.A., Stott G.A., et al. Control of methicillin resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 16 (1995) 686-696
93. Jans B., Suetens C., and Struelens M. Decreasing MRSA rates in Belgian hospitals: results from the national surveillance network after introduction of national guidelines. Infect Control Hosp Epidemiol 21 (2000) 419
94. Back N.A., Linnemann Jr. C.C., Staneck J.L., and Kotagal U.R. Control of methicillin-resistant Staphylococcus aureus in a neonatal intensive-care unit: use of intensive microbiologic surveillance and mupirocin. Infect Control Hosp Epidemiol 17 (1996) 227-231
95. Calfee D.P., and Farr B.M. Infection control and cost control in the era of managed care. Infect Control Hosp Epidemiol 23 (2002) 407-410
96. Law M.R., and Gill O.N. Hospital-acquired infection with methicillin-resistant and methicillin-sensitive staphylococci. Epidemiol Infect 101 (1988) 623-629
97. Murray-Leisure K.A., Geib S., Graceley D., et al. Control of epidemic methicillin resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 11 (1990) 343-350
98. Nicolle L.E., Dyck B., Thompson G., et al. Regional dissemination and control of epidemic methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 20 (1999) 202-205
99. Kotilainen P., Routamaa M., Peltonen R., et al. Eradication of methicillin-resistant Staphylococcus aureus from a health center ward and associated nursing home. Arch Intern Med 161 (2001) 859-863
100. Geffers C., and Farr B.M. Risk of transmission of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) from patients colonized with MRSA. Infect Control Hosp Epidemiol 26 (2005) 114-115
101. Vriens M.R., Fluit A.C., Troelstra A., Verhoef J., and Van Der Werken C. Are MRSA more contagious than MSSA in a surgical intensive care unit?. Infect Control Hosp Epidemiol 23 (2002) 491-494
102. Forceville X., Faibis F., Lahilaire P., et al. Decrease of infection rate of methicillin resistant Staphylococcus aureus acquired in a French intensive care unit, under reinforcement of specific isolation. Med Mal Infect 32 (2002) 346-358
103. Pan A., Carnevale G., Catenazzi, et al. Trends in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: effect of the MRSA 'search and isolate' strategy in a hospital in Italy with hyperendemic MRSA. Infect Control Hosp Epidemiol 26 (2005) 127-133
104. Bannister B.A. Management of patients with epidemic methicillin-resistant Staphylococcus aureus: experience at an infectious diseases unit. J Hosp Infect 9 (1987) 126-131
105. Vriens M.R., Blok H.E.M., Gigengack A.C.M., et al. Methicillin-resistant Staphylococcus aureus carriage among patients after hospital discharge. Infect Control Hosp Epidemiol 26 (2005) 629-633
106. Loeb M., Main C., Walker-Dilks C., and Eady A. Antimicrobial drugs for treating meticillin resistant Staphylococcus aureus colonisation. [Cochrane Review]. The Cochrane Library, Issue 3 (2003), John Wiley & Sons, Ltd, Chichester
107. The AGREE Collaboration. Appraisal of guidelines for research and evaluation (AGREE) instrument (2001), St. Georges Hospital Medical School, London. Available from: www.agreecollaboration.org
108. Doebbeling B.N., Breneman D.L., Neu H.C., et al. Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with mupirocin calcium ointment. The Mupirocin Collaborative Study Group. Clin Infect Dis 17 (1993) 466-474
109. Karchmer TB, Jernigan JA, Simonton BM, Farr BM. Eradication of meticillin-resistant S. aureus (MRSA) colonisation with different regimens. Presented at the Ninth Annual Meeting of the Society for Healthcare Epidemiology of America, 18-20 April 1999, San Francisco, CA, USA. Abstract 65.
110. Walker E.S., Vasquez J.E., Dula R., Bullock H., and Sarubbi F.A. Mupirocin-resistant meticillin-resistant Staphylococcus aureus: does mupirocin remain effective?. Infect Control Hosp Epidemiol 24 (2003) 342-346
111. Hitomi S., Kubota M., Mori N., et al. Control of meticillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by selective use of nasal mupirocin ointment. J Hosp Infect 46 (2000) 123-129
112. Dupeyron C., Campillo B., Bordes M., Faubert E., Richardet J.P., and Mangeney N. A clinical trial of mupirocin in the eradication of meticillin-resistant Staphylococcus aureus nasal carriage in a digestive diseases unit. J Hosp Infect 52 (2002) 281-287
113. Wang J.T., Lin S.F., Chiu L., et al. Molecular epidemiology and control of nosocomial meticillin-resistant Staphylococcus aureus infection in a teaching hospital. J Formos Med Assoc 103 (2004) 32-36
114. Maraha B., van Halteren J., Verzijl J.M., Wintermans R.G., and Buiting A.G. Decolonisation of meticillin-resistant Staphylococcus aureus using oral vancomycin and topical mupirocin. Clin Microbiol Infect 8 (2002) 671-675
115. Wilcox M.H., Hall J., Pike H., et al. Use of peri-operative mupirocin to prevent meticillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infection. J Hosp Infect 54 (2003) 196-201
116. Mody L., Kauffman C.A., McNeil S.A., Galecki A.T., and Bradley S.F. Mupirocin-based decolonisation of Staphylococcus aureus carriers in residents of 2 long term care facilities: a randomised, double-blind, placebo-controlled trial. Clin Infect Dis 37 (2003) 1467-1474
117. Department of Health. Hospital infection control: guidance on the control of infection in hospitals. Prepared by the Hospital Infection Working Group of the Department of Health and PHLS (1995), Department of Health, London
118. Department of Health. Winning ways: working together to reduce healthcare associated infection in England. Report from the Chief Medical Officer (2003), Department of Health, London
119. Department of Health. Infection control in the built environment. HBN 30. London: NHS Estates; 2002.
120. Department of Health. In patient accommodation: options for choice. Supplement 1. Isolation facilities in acute settings. HBN 4. London: NHS Estates; 1997.
121. Report by the Controller and Auditor General. Improving patient care by reducing the risk of hospital acquired infection: a progress report. HC 876 Session 2003-2004; London: HMSO 2004.
122. Department of Health. Standards for better health (2004-2004), Department of Health, London. http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4086665&chk=jXDWU6 Last accessed 30 October 2005
123. Cooper B.S., Stone S.O., Kibbler C.C., et al. Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. Health Technol Assess 7 (2003) 1-194
124. Department of Health. The patient's charter: privacy and dignity and the provision of single sex accommodation (1997-1997), Department of Health, London. http://www.dh.gov.uk/assetRoot/04/01/14/24/04011424.pdf Last accessed 30 October 2005
125. Boyce J.M., and Pittet D. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol 23 Suppl. (2002) S3-S41
126. Ayliffe G.A.J., Babb J.R., and Taylor L.J. Hospital-acquired infection. Principles and prevention. 3rd ed. (1999), Butterworth-Heinemann, Oxford
127. French G.L., Otter J.A., Shannon K.P., et al. Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J Hosp Infect 57 (2004) 31-37
128. Duckworth G.L., and Jordens J.Z. Adherence and survival properties of an 'epidemic' methicillin-resistant strain of Staphylococcus aureus compared with those of methicillin-sensitive strains. J Med Microbiol 32 (1990) 195-200
129. Wiseman S. Implementing effective infection control in the hospital. Nurs Times 100 (2004) 36
130. NHS Estates. Standards for cleanliness in the NHS: a framework in which to measure performance outcomes (2003), NHS Estates, Leeds. http://www.patientexperience.nhsestates.gov.uk/clean_hospitals/ch_content/home/home.asp Accessed 28 May 2005
131. Health Care Standards Unit. Standards for better health. Signpost C4e (Waste). London: HMSO. http://www.hcsu.org.uk/index.phf?option=com_content&task=view&id=47&Itemid=0 Accessed 28 May 2005
132. NHS Executive. Hospital laundry arrangements for used and infected linen. HSG(95)18 (1995), Health Publications Unit, Heywood
133. Ayliffe G.A.J., Fraise A.P., Geddes A.M., and Mitchell K. Control of hospital infection. A practical handbook. 4th ed. (2000), Arnold, London
134. Hoffman P.N., Williams J., Stacey A., et al. Report of a Working Party of the Hospital Infection Society. Microbiological commissioning and monitoring of operating theatre suites. J Hosp Infect 52 (2002) 1-28
135. Haley R.W., and Bregman D.A. The role of understaffing and overcrowding in recent outbreaks of staphylocccal infection in a neonatal special-care unit. J Infect Dis 145 (1982) 875-885
136. Arnow P.M., Allyn P.A., Nichols E.M., Hill D.L., Pezzio M., and Bartlett R.H. Control of methicillin resistant Staphylococcus aureus in a burn unit: role of nurse staffing. J Trauma 22 (1982) 954-959
137. Fridkin S.K., Pear S.M., Williamson T.H., Galgiani J.N., and Jarvis W.R. The role of understaffing in central venous catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 17 (1996) 150-158
138. Vicca A.F. Nursing staff workload as a determinant of methicillin-resistant Staphylococcus aureus spread in an adult intensive care unit. J Hosp Infect 43 (1999) 109-113
139. Harbarth S., Sudre P., Dharan S., Cadenas M., and Pittet D. Outbreak of Enterobacter cloacae related to understaffing, overcrowding, and poor hygiene practices. Infect Control Hosp Epidemiol 20 (1999) 598-603
140. Pittet D. Improving compliance with hand hygiene in hospitals. Infect Control Hosp Epidemiol 21 (2000) 381-386
141. HICPAC. Guideline for hand hygiene in health-care settings. MMWR Morb Mortal Wkly Rep 51 (2002) RR-16. http://www.cdc.gov/mmwr/PDF/rr/rr5116.pdf Last accessed 23 January 2006
142. Voss A., and Widmer A.F. No time for handwashing!? Handwashing versus alcoholic rub: can we afford 100% compliance?. Infect Control Hosp Epidemiol 18 (1997) 205-208
143. Pittet D., Mourouga P., and Perneger T.V. Compliance with hand washing in a teaching hospital. Ann Int Med 130 (1999) 126-130
144. Farrington M., Trundle C., Redpath C., and Anderson L. Effects on nursing workload of different MRSA control strategies. J Hosp Infect 46 (2000) 118-122
145. Epic Guideline Project. The epic project: developing national evidence-based guidelines for preventing healthcare association infections phase 1: guidelines for preventing hospital-acquired infections. London: HMSO (2001). http://www.dh.gov.uk/assetRoot/04/07/73/68/04077368.pdf Last accessed 27 January 2006
146. Stone P.W., Clark S.P., Cimiotti J., and Corres-de-Araujo R. Nurses' working conditions: implications for infectious disease. Emerg Infect Dis 10 (2004) 1984-1989
147. Kovner C., Jones C., Zhan C., Gergen P.J., and Basu J. Nurse staffing and postsurgical adverse events: an analysis of administrative data from a sample of U.S. hospitals, 1990-1996. Health Serv Res 37 (2002) 611-629
148. Alonso-Echanove J, Edwards JR, Richards MJ, et al. Effect of nurse staffing and antimicrobial-impregnated central venous catheters on the risk for bloodstream infections in intensive care units. Infect Control Hosp Epidemiol 2003;2:916-925.
149. Anderson B.M., Lindemann R., Bergh R., et al. Spread of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit associated with understaffing, overcrowding and mixing of patients. J Hosp Infect 50 (2002) 18-24
150. Stenenga J., Bell E., and Matlow A. The role of nurse understaffing in nosocomial viral gastrointestinal infections on a general pediatrics ward. Infect Control Hosp Epidemiol 23 (2002) 133-136
151. Amravadi R.K., Jacobson B.C., Solomon D.H., and Fischer M.A. ICU nurse-to-patient ratio is associated with complications and resource use after esophagectomy. Inten Care Med 26 (2000) 1857-1862
152. Robert J., Fridkin S.K., Blumberg H.M., et al. The influence of the composition of the nursing staff on primary bloodstream infection rates in a surgical intensive care unit. Infect Control Hosp Epidemiol 21 (2000) 12-17
153. Kovner C., and Gergen P.J. Nurse staffing levels and adverse events following surgery in U.S. hospitals. J Nurse Scholarsh 30 (1998) 315-321
154. Archibald L.K., Manning M.L., Bell L.M., Banerjee S., and Jarvis W.R. Patient density, nurse-to-patient ratio and nosocomial infection risk in a pediatric intensive care unit. Pediatr Infect Dis J 16 (1997) 1045-1048
155. Working Party of the British Society for Antimicrobial Chemotherapy. Supplementary report. J Antimicrob Chemother 38 (1996) 1103-1105
156. National Committee for Clinical Laboratory Standards. Methods for dilution. Antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, M7-A4. 4th edn. (1997), NCCLS, Vilanova
157. Kaplan A.H., Gilligan P.H., and Facklam R.R. Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol 26 (1988) 1216-1218
158. Noble W.C., Virani Z., and Cree R.G. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 72 (1992) 195-198
159. Hiramatsu K., Hanaki H., Ino T., Yabuta K., Oguri T., and Tenover F.C. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40 (1997) 135-136
160. Fridkin S.K., Hageman J., McDougal L.K., et al. Vancomycin-intermediate Staphylococcus aureus Epidemiology Study Group. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis 36 (2003) 429-439
161. Smith T.L., Pearson M.L., Wilcox K.R., et al. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-intermediate Staphylococcus aureus Working Group. N Engl J Med 340 (1999) 493-501
162. Rotun S.S., McMath V., Schoonmaker D.J., et al. Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia. Emerg Infect Dis 5 (1999) 147-149
163. Khurshid M.A., Chou T., Carey R., et al. Staphylococcus aureus with reduced susceptibility to vancomycin - Illinois, 1999. MMWR Morb Mortal Wkly Rep 48 (2000) 1165-1167
164. Naimi T.S., Anderson D., O'Boyle C., et al. Vancomycin-intermediate Staphylococcus aureus with phenotypic susceptibility to methicillin in a patient with recurrent bacteremia. Clin Infect Dis 36 (2003) 1609-1612
165. Hageman J.C., Pegues D.A., Jepson C., et al. Vancomycin-intermediate Staphylococcus aureus in a home health-care patient. Emerg Infect Dis 7 (2001) 1023-1025
166. Walsh T.R., and Howe R.A. The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. Ann Rev Microbiol 56 (2002) 657-675
167. Weigel L.M., Clewell D.B., Gill S.R., et al. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302 (2003) 1569-1571
168. Tenover F.C., Weigel L.M., Appelbaum P.C., et al. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother 48 (2004) 275-280
169. Ike Y., Arakawa Y., Ma X., et al. Nationwide survey shows that methicillin-resistant Staphylococcus aureus strains heterogeneously and intermediately resistant to vancomycin are not disseminated throughout Japanese hospitals. J Clin Microbiol 39 (2001) 4445-4451
170. Ploy M.C., Grelaud C., Martin C., de Lumley L., and Denis F. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet 351 (1998) 9110-9112
171. Bierbaum G., Fuchs K., Lenz W., Szekat C., and Sahl H.G. Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany. Eur J Clin Microbiol Infect Dis 18 (1999) 691-696
172. Howe R.A., Bowker K.E., Walsh T.R., Feest T.G., and MacGowan A.P. Vancomycin-resistant Staphylococcus aureus. Lancet 351 (1998) 602
173. Ariza J., Pujol M., Cabo J., et al. Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin. Lancet 353 (1999) 1587-1588
174. Wong S.S., Ho P.L., Woo P.C., and Yuen K.Y. Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. Clin Infect Dis 29 (1999) 760-767
175. Kantzanou M., Tassios P.T., Tseleni-Kotsovili A., Legakis N.J., and Vatopoulos A.C. Reduced susceptibility to vancomycin of nosocomial isolates of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 43 (1999) 729-731
176. Marchese A., Balistreri G., Tonoli E., Debbia E.A., and Schito G.C. Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital. J Clin Microbiol 38 (2000) 866-869
177. Ward P.B., Johnson P.D., Grabsch E.A., Mayall B.C., and Grayson M.L. Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin. Med J Aust 175 (2001) 480-483
178. Oliveira G.A., Dell'Aquila A.M., Masiero R.L., et al. Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin. Infect Control Hosp Epidemiol 22 (2001) 443-448
179. Kim M.N., Hwang S.H., Pyo Y.J., Mun H.M., and Pai C.H. Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea. J Clin Microbiol 40 (2002) 1376-1380
180. Krzyszton-Russjan J., Gniadkowski M., Polowniak-Pracka H., Hagmajer E., and Hryniewicz W. The first Staphylococcus aureus isolates with reduced susceptibility to vancomycin in Poland. J Antimicrobial Chemother 50 (2002) 1065-1069
181. Tenover F.C. Implications of vancomycin-resistant Staphylococcus aureus. J Hosp Infect 43 Suppl (1999) S3-S7
182. Tenover F.C., Lancaster M.V., Hill B.C., et al. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol 36 (1998) 1020-1027
183. Edmond M.B., Wenzel R.P., and Pasculle A.W. Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control. Ann Intern Med 124 (1996) 329-334
184. Hospital Infection Control Practises Advisory Committee, CDC, Atlanta, USA Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin. MMWR Morb Mortal Wkly Rep 46 (1997) 626-628
185. D'Agata E.M. Antimicrobial-resistant, Gram-positive bacteria among patients undergoing chronic hemodialysis. Clin Infect Dis 35 (2002) 1212-1218
186. Hiramatsu K., Aritaka N., Hanaki H., et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350 (1997) 1670-1673
187. Ploy M.C., Francois B., Mounier M., Vignon P., and Denis F. Nasal carriage of vancomycin-intermediate Staphylococcus aureus among intensive care unit staff. Clin Infect Dis 33 (2001) 1951
188. World Health Organization. Report on infectious diseases (2000), World Health Organization, Geneva. Available from: www.who.int/infectious-disease-report/2000/index.html Last accessed 25 January 2006
189. Wenzel R.P., and Edmond M.B. Vancomycin-resistant Staphylococcus aureus: infection control considerations. Clin Infect Dis 27 (1998) 245-249
190. Kralovic S.M., Danko L.H., and Roselle G.A. Laboratory reporting of Staphylococcus aureus with reduced susceptibility to vancomycin in United States Department of Veterans Affairs Facilities. Emerg Infect Dis 8 (2002) 402-407
191. Tenover F.C., Biddle J.W., and Lancaster M.V. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg Infect Dis 7 (2001) 327-332
192. Hussain F.M., Boyle-Vavra S., Shete P.B., and Daum R.S. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates. J Infect Dis 186 (2002) 661-667
193. Midolo P.D., Korman T.M., Kotsanas D., Russo P., and Kerr T.G. Laboratory detection and investigation of reduced susceptibility to vancomycin in oxacillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 22 (2003) 199-201
194. Wootton M., Howe R.A., Hillman R., Walsh T.R., Bennett P.M., and MacGowan A.P. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J Antimicrob Chemother 47 (2001) 399-403 Erratum appears in J Antimicrob Chemother 2001;48:161
195. Howe R.A., Wootton M., Walsh T.R., Bennett P.M., and MacGowan A.P. Heterogeneous resistance to vancomycin in Staphylococcus aureus. J Antimicrob Chemother 45 (2000) 130-131
196. National Institute for Clinical Excellence. Infection control: prevention of healthcare associated infection in primary and community care (2003), NICE, London